US FDA chief: Companies asked to be prepared to ramp up production of leucovorin
WASHINGTON, Sept 22 (Reuters) - The Trump administration has asked drug companies to be prepared to ramp up production of leucovorin as a treatment for some autism patients, FDA chief Marty Makary told reporters on Monday.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Why SanDisk Stock Could Soar to $4,000?

US-Iran Tensions Heat Up Again, Brent Crude Prices Return Above $100

Trump Administration Brokers. Intel and Apple Reach Chipmaking Agreement, Shares Surge More Than 13%

AI Chip Sector Adds Heavyweight Player, Nvidia Rival Cerebras Plans to List Next Week, Targeting Largest US IPO of the Year

GOOGL Stock: Should You Buy the Best-Performing Magnificent Seven Stock Right Now?

Tradingkey






